Skip to main content
. 2018 Mar 7;9:335. doi: 10.3389/fimmu.2018.00335

Table 6.

Seroprevalence of AdHu5 and AdC68 neutralizing antibody in subjects with different pathological type of lung cancer.

AdHu5 AdC68 P-value
Squamous cell carcinoma 72.50% (29/40) 70.00% (28/40) 0.805
Adenocarcinoma 77.50% (31/40) 35.00% (14/40) 0.008